11 Best Drug Stocks to Buy According to Hedge Funds
Health and Human Services Secretary Robert F. Kennedy Jr.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 13,458,826 | $820,853,797 | +2% | 2.87% |
| 2. | GQG Partners Rajiv Jain | 12,023,454 | $733,310,434 | +22648% | 1.17% |
| 3. | AQR Capital Management Cliff Asness | 5,969,030 | $364,051,115 | +49% | 0.38% |
| 4. | 4,732,400 | $288,629,076 | -2% | 0.05% | |
| 5. | 3,568,200 | $217,624,518 | -10% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.58 | 4,250 | Officer | 83,513 | 2025-04-25 | Filing | |
| $55.05 | 2,000 | Officer, Director | 104,626 | 2025-02-20 | Filing | |
| $54.84 | 1,823 | Officer | 63,932 | 2025-02-14 | Filing | |
| $54.68 | 1,830 | Officer | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | Officer | 82,672 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.01 | 97 | Officer | 0 | 2025-05-09 | Filing | |
| $55.62 | 700 | Officer | 11,760 | 2024-11-04 | Filing | |
| $61.25 | 17,986 | Officer | 27,868 | 2023-08-24 | Filing | |
| $61.14 | 732 | Officer | 6,584 | 2023-08-03 | Filing | |
| $67.06 | 50,385 | Officer | 47,751 | 2023-05-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 191,403,004 | $11,673,669,214 | 0.21% | |
| 2. | 161,366,354 | $9,841,733,950 | 0.21% | |
| 3. | 108,052,504 | $6,590,122,241 | 0.48% | |
| 4. | 94,834,478 | $5,783,954,813 | 0.24% | |
| 5. | 66,465,773 | $4,053,211,252 | 0.8% |
News See All
15 Best Stocks to Invest in for an 18 Year Old
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable effect on inflation...
Jim Cramer Commented on These 17 Stocks
On Friday, Mad Money host Jim Cramer shared his evolving view of Elon Musk’s company as he provided both praise and caution in light of recent developments involving Musk and President Donald Trump.
Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Bristol-Myers Squibb Co.
Was Jim Cramer Right About These 9 Stocks?
During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies depend on China, during a time when the U.S.
Bristol-Myers Squibb Company and BioNTech SE Partner to Advance Next-Gen Cancer Therapies
Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the global biopharmaceutical market.
Bristol-Myers (BMY) Licenses BioNTech's Immunotherapy in $11 billion Deal
On Monday, June 2, Bloomberg reported that Bristol-Myers Squibb Company (NYSE:BMY) and BioNTech SE (NASDAQ:BNTX) announced a strategic licensing agreement focused on next-generation oncology therapies...
Jim Cramer On Bristol-Myers Squibb: "Waiting For It To Bottom"
“Let's get started with the stocks that sold off hard today, because I think it's really important, because you know most, if not all, of these companies.
Jim Cramer Commented on 7 Hard-to-Own Safety Stocks
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Billionaire Hedge Funds
